June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
An automated, structure-function method for detecting progression of glaucoma
Author Affiliations & Notes
  • Emmanouil (Manos) Tsamis
    Psychology, Columbia University, New York, New York, United States
  • Sol La Bruna
    Psychology, Columbia University, New York, New York, United States
  • Ari Leshno
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Anvit Rai
    Psychology, Columbia University, New York, New York, United States
    Albert Einstein College of Medicine, Bronx, New York, United States
  • George A Cioffi
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Carlos G DeMoraes
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Donald C Hood
    Psychology, Columbia University, New York, New York, United States
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Emmanouil (Manos) Tsamis None; Sol La Bruna None; Ari Leshno None; Anvit Rai None; George Cioffi None; Jeffrey Liebmann None; Carlos DeMoraes Carl Zeiss, Novartis, Thea, Allergan, Code C (Consultant/Contractor), ORA Clinical, Code E (Employment), Topcon Inc., Heidelberg Eng., Code R (Recipient); Donald Hood Topcon Inc., Heidelberg Eng., Novartis, Code C (Consultant/Contractor), Topcon Inc., Heidelberg Eng., Novartis, Code F (Financial Support), Topcon Inc., Heidelberg Eng., Code R (Recipient)
  • Footnotes
    Support  NIH / NEI Grant K99EY032182
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 831. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emmanouil (Manos) Tsamis, Sol La Bruna, Ari Leshno, Anvit Rai, George A Cioffi, Jeffrey M Liebmann, Carlos G DeMoraes, Donald C Hood; An automated, structure-function method for detecting progression of glaucoma. Invest. Ophthalmol. Vis. Sci. 2022;63(7):831.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop and test an automated method for detecting progression based upon topographical agreement of changes in the optical coherence tomography (OCT) maps and 24-2 and 10-2 visual fields (VF) in eyes with early glaucoma.

Methods : Widefield OCT (12x9mm) scans and 24-2 and 10-2 VFs were acquired from 55 eyes with early or suspected glaucoma (baseline 24-2 mean deviation >-6dB) and 25 healthy controls (HC) as part of a longitudinal, prospective study. Baseline (V1) OCT maps and VFs were compared to those from the last follow-up visit (V2), which was obtained at least 1 year later. Continuous probability change (pc-) maps were determined for both the retinal nerve fiber layer (RNFL) and retinal ganglion cell plus inner plexiform layer (GCL+) (Fig. 1) by comparing the difference of the thickness between V1 and V2 to an estimation of short-term variability for scans within 4 months. Red (p<1%) and yellow (p<5%) in Figs. 1 & 2 indicate significant change. The same approach was applied for the VFs. A custom R program [1] superimposed VF locations on RNFL and GCL+ pc-maps and determined the number of locations with both progressive structural (pS, p<10%) and functional (pF, p<5%) change (diamonds in Figs. 1&2). The criterion number of pS-pF locations for a 95% specificity was estimated based upon sampling the HC group with replacement. A reference standard based upon experts’ evaluation of V1 and V2 OCT data (b-scans, and RNFL and GCL thickness and change maps) and VF tests identified 12 progressing (P) eyes.

Results : For the HC eyes, a threshold of 10 total pS-pF locations on the RNFL and GCL+ pc-maps achieved a specificity of 95% (1 HC false positive). The same threshold identified 8 eyes as ‘progressors’, 7 of which were true positives (sensitivity from 12 P eyes: 58%). A post-hoc analysis of the other 5 P eyes revealed that 4 of the 5 showed a very narrow progressive region on the OCT with pS-pF agreement within the same arcuate region, but no overlap (Fig. 2). The commercial GPA correctly identified only 4 of the 12 P eyes (sensitivity: 33%).

Conclusions : An automated method for detecting progression based upon topographical OCT and VF agreement showed good specificity and identified more P eyes than the commercial GPA. Eyes with narrow arcuate progression can still be missed, mainly due to the spatial resolution of the 24-2 and the limited extend of the OCT scan size. 1. Tsamis et al, TVST, 2020.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×